ZWINT is a Promising Therapeutic Biomarker Associated with the Immune Microenvironment of Hepatocellular Carcinoma

References

• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer. Available from: https://gco.iarc.fr/today. Accessed March 25, 2021.
   Google Scholar
• Duran SR, Jaquiss R. Hepatocellular carcinoma. N Engl J Med. 2019;381(1):e2. doi:10.1056/NEJMc1906565
   PubMed Web of Science ®Google Scholar
• Lin YT, Chen Y, Wu G, et al. Hec1 sequentially recruits Zwint-1 and ZW10 to kinetochores for faithful chromosome segregation and spindle checkpoint control. Oncogene. 2006;25(52):6901–6914. doi:10.1038/sj.onc.1209687
   PubMed Web of Science ®Google Scholar
• de Wolf B, Kops G. Kinetochore malfunction in human pathologies. Adv Exp Med Biol. 2017;1002:69–91. doi:10.1007/978-3-319-57127-0_4
   PubMed Web of Science ®Google Scholar
• Wang H, Hu X, Ding X, et al. Human Zwint-1 specifies localization of Zeste White 10 to kinetochores and is essential for mitotic checkpoint signaling. J Biol Chem. 2004;279(52):54590–54598. doi:10.1074/jbc.M407588200
   PubMed Web of Science ®Google Scholar
• Woo SD, Yeop YS, Chung WJ, et al. Zwint-1 is required for spindle assembly checkpoint function and kinetochore-microtubule attachment during oocyte meiosis. Sci Rep. 2015;5:(15431. doi:10.1038/srep15431
   Web of Science ®Google Scholar
• Song X, Du R, Gui H, et al. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis. Oncol Rep. 2020;43(1):133–146. doi:10.3892/or.2019.7400
   PubMed Web of Science ®Google Scholar
• Xu Z, Zhou Y, Cao Y, et al. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis. Med Oncol. 2016;33(11):130. doi:10.1007/s12032016-0840-y
   PubMed Web of Science ®Google Scholar
• Li HN, Zheng WH, Du YY, et al. ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: an integrated bioinformatics analysis. Oncol Lett. 2020;19(3):2163–2174. doi:10.3892/ol.2020.11353
   PubMed Web of Science ®Google Scholar
• Yang L, Han N, Zhang X, et al. Zwint: a potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Oncol Rep. 2020;43(6):1831–1844. doi:10.3892/or.2020.7573
   PubMed Web of Science ®Google Scholar
• Liang C. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma. World J Hepatol. 2015;7(10):1390. doi:10.4254/wjh.v7.i10.1390
   PubMedGoogle Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia. 2007;9(2):166–180. doi:10.1593/neo.07112
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya S, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.002
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–D963. doi:10.1093/nar/gkx1090
   PubMed Web of Science ®Google Scholar
• Menyhárt O, Nagy Á, Győrffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(12):181006. doi:10.1098/rsos.181006
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. doi:10.1158/2159-8290.CD12-0095
   PubMed Web of Science ®Google Scholar
• Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioportal. Sci Signal. 2013;6(269):l1. doi:10.1126/scisignal.2004088
   Web of Science ®Google Scholar
• Modhukur V, Iljasenko T, Metsalu T, et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics-Uk. 2018;10(3):277–288. doi:10.2217/epi-2017-0118
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang J, Jaehnig EJ, et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199–W205. doi:10.1093/nar/gkz401
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4(2). doi:10.1186/1471-2105-4-2
   Web of Science ®Google Scholar
• Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. doi:10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, et al. CytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8 Suppl 4(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202. doi:10.1093/bioinformatics/btz210
   PubMed Web of Science ®Google Scholar
• Pan J, Zhou H, Cooper L, et al. LAYN is a prognostic biomarker and correlated with immune infiltrates in gastric and colon cancers. Front Immunol. 2019;10(6). doi:10.3389/fimmu.2019.00006
   Web of Science ®Google Scholar
• Xiao Z, Hu L, Yang L, et al. TGFβ2 is a prognostic‐related biomarker and correlated with immune infiltrates in gastric cancer. J Cell Mol Med. 2020;24(13):7151–7162. doi:10.1111/jcmm.15164
   PubMed Web of Science ®Google Scholar
• Ovejero S, Bueno A, Sacristán MP. Working on genomic stability: from the s-phase to mitosis. Genes. 2020;11(2):225. doi:10.3390/genes11020225
   PubMed Web of Science ®Google Scholar
• Benzi G, Piatti S. Killing two birds with one stone: how budding yeast MPS1 controls chromosome segregation and spindle assembly checkpoint through phosphorylation of a single kinetochore protein. Curr Genet. 2020;66(6):1037–1044. doi:10.1007/s00294-020-01091-x
   PubMed Web of Science ®Google Scholar
• Ying H, Xu Z, Chen M, et al. Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins. Oncotargets Ther. 2018;11:689–702. doi:10.2147/OTT.S152138
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhang Q, Liu M, et al. Identification of DNA repair-related genes predicting pathogenesis and prognosis for liver cancer. Cancer Cell Int. 2021;21(1):81. doi:10.1186/s12935-021-01779-1
   PubMed Web of Science ®Google Scholar
• Enders GH, Maude SL. Traffic safety for the cell: influence of cyclin-dependent kinase activity on genomic stability. Gene. 2006;371(1):1–6. doi:10.1016/j.gene.2005.11.017
   PubMed Web of Science ®Google Scholar
• Łukasik P, Załuski M, Gutowska I. Cyclin-dependent kinases (CDK) and their role in diseases development-review. Int J Mol Sci. 2021;22(6):2935. doi:10.3390/ijms22062935
   PubMed Web of Science ®Google Scholar
• Palmer N, Kaldis P. Less-well known functions of cyclin/CDK complexes. Semin Cell Dev Biol. 2020;107:54–62. doi:10.1016/j.semcdb.2020.04.003
   PubMed Web of Science ®Google Scholar
• Araki H. Cyclin-dependent kinase-dependent initiation of chromosomal DNA replication. Curr Opin Cell Biol. 2010;22(6):766–771. doi:10.1016/j.ceb.2010.07.015
   PubMed Web of Science ®Google Scholar
• Lin DI, Aggarwal P, Diehl JA. Phosphorylation of MCM3 on Ser-112 regulates its incorporation into the MCM2–7 complex. Proc Natl Acad Sci U S A. 2008;105(23):8079–8084. doi:10.1073/pnas.0800077105
   PubMed Web of Science ®Google Scholar
• Wei Q, Li J, Liu T, et al. Phosphorylation of minichromosome maintenance protein 7 (MCM7) by cyclin/cyclin-dependent kinase affects its function in cell cycle regulation. J Biol Chem. 2013;288(27):19715–19725. doi:10.1074/jbc.M112.449652
   PubMed Web of Science ®Google Scholar
• Mughal MJ, Mahadevappa R, Kwok HF. DNA replication licensing proteins: saints and sinners in cancer. Semin Cancer Biol. 2019;58:11–21. doi:10.1016/j.semcancer.2018.11.009
   PubMed Web of Science ®Google Scholar
• Li X, Huang W, Huang W, et al. Kinesin family members KIF2C/4A/10/11/14/18B/20A/23 predict poor prognosis and promote cell proliferation in hepatocellular carcinoma. Am J Transl Res. 2020;12(5):1614–1639.
   PubMed Web of Science ®Google Scholar
• Hu ZD, Jiang Y, Sun HM, et al. KIF11 promotes proliferation of hepatocellular carcinoma among patients with liver cancers. Biomed Res Int. 2021;2021:2676745. doi:10.1155/2021/2676745
   PubMed Web of Science ®Google Scholar
• Horsfall AJ, Abell AD, Bruning JB. Targeting PCNA with peptide mimetics for therapeutic purposes. Chembiochem. 2020;21(4):442–450. doi:10.1002/cbic.201900275
   PubMed Web of Science ®Google Scholar
• Lv Q, Zhang J, Yi Y, et al. Proliferating cell nuclear antigen has an association with prognosis and risks factors of cancer patients: a systematic review. Mol Neurobiol. 2016;53(9):6209–6217. doi:10.1007/s12035-015-9525-3
   PubMed Web of Science ®Google Scholar
• Mei J, Wang R, Xia D, et al. Brca1 is a novel prognostic indicator and associates with immune cell infiltration in hepatocellular carcinoma. DNA Cell Biol. 2020;39(10):1838–1849. doi:10.1089/dna.2020.5644
   PubMed Web of Science ®Google Scholar
• Keijzers G, Bakula D, Petr MA, et al. Human exonuclease 1 (EXO1) regulatory functions in DNA replication with putative roles in cancer. Int J Mol Sci. 2018;20(1). doi:10.3390/ijms20010074
   PubMed Web of Science ®Google Scholar
• Yang G, Dong K, Zhang Z, et al. EXO1 plays a carcinogenic role in hepatocellular carcinoma and is related to the regulation of FOXP3. J Cancer. 2020;11(16):4917–4932. doi:10.7150/jca.40673
   PubMed Web of Science ®Google Scholar
• Dai Y, Tang Z, Yang Z, et al. EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients. Cell Cycle. 2018;17(19–20):2386–2397. doi:10.1080/15384101.2018.1534511
   PubMed Web of Science ®Google Scholar
• Du R, Huang C, Liu K, et al. Targeting AURKA in cancer: molecular mechanisms and opportunities for cancer therapy. Mol Cancer. 2021;20(1):15. doi:10.1186/s12943-020-01305-3
   PubMed Web of Science ®Google Scholar
• Endig J, Buitrago-Molina LE, Marhenke S, et al. Dual role of the adaptive immune system in liver injury and hepatocellular carcinoma development. Cancer Cell. 2016;30(2):308–323. doi:10.1016/j.ccell.2016.06.009
   PubMed Web of Science ®Google Scholar
• Lu C, Rong D, Zhang B, et al. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Mol Cancer. 2019;18(1). doi:10.1186/s12943019-1047-6
   Web of Science ®Google Scholar
• Chaib M, Chauhan SC, Makowski L. Friend or foe? Recent strategies to target myeloid cells in cancer. Front Cell Dev Biol. 2020;8:(351. doi:10.3389/fcell.2020.00351
   PubMed Web of Science ®Google Scholar
• Sittig SP, de Vries I, Schreibelt G. Primary human blood dendritic cells for cancer immunotherapy tailoring the immune response by dendritic cell maturation. Biomedicines. 2015;3(4):282–303. doi:10.3390/biomedicines3040282
   PubMedGoogle Scholar
• Volovitz I, Melzer S, Amar S, et al. Dendritic cells in the context of human tumors: biology and experimental tools. Int Rev Immunol. 2016;35(2):116–135. doi:10.3109/08830185.2015.1096935
   PubMed Web of Science ®Google Scholar
• Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Front Oncol. 2019;9:1146. doi:10.3389/fonc.2019.01146
   PubMed Web of Science ®Google Scholar
• Piccard H, Muschel RJ, Opdenakker G. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol. 2012;82(3):296–309. doi:10.1016/j.critrevonc.2011.06.004
   PubMed Web of Science ®Google Scholar
• Keeley T, Costanzo-Garvey DL, Cook LM. Unmasking the many faces of tumor-associated neutrophils and macrophages: considerations for targeting innate immune cells in cancer. Trends Cancer. 2019;5(12):789–798. doi:10.1016/j.trecan.2019.10.013
   PubMed Web of Science ®Google Scholar
• Schupp J, Krebs FK, Zimmer N, et al. Targeting myeloid cells in the tumor sustaining microenvironment. Cell Immunol. 2019;343:103713. doi:10.1016/j.cellimm.2017.10.013
   PubMed Web of Science ®Google Scholar
• Yang Y, Kim S, Seki E. Inflammation and liver cancer: molecular mechanisms and therapeutic targets. Semin Liver Dis. 2019;39(01):26–42. doi:10.1055/s-0038-1676806
   PubMed Web of Science ®Google Scholar
• Richardson JR, Schöllhorn A, Gouttefangeas C, et al. CD4+ T cells: multitasking cells in the duty of cancer immunotherapy. Cancers. 2021;13(4):596. doi:10.3390/cancers13040596
   PubMed Web of Science ®Google Scholar
• Ringelhan M, Pfister D, Connor O, et al. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(3):222–232. doi:10.1038/s41590-018-0044-z
   PubMed Web of Science ®Google Scholar
• Garnelo M, Tan A, Her Z, et al. Interaction between tumour-infiltrating b cells and t cells controls the progression of hepatocellular carcinoma. Gut. 2017;66(2):342–351. doi:10.1136/gutjnl-2015-310814
   PubMed Web of Science ®Google Scholar